Applications and continued evolution of glycan imaging mass spectrometry. Issue 2 (15th August 2021)

• Record Type: Journal Article
• Authors: McDowell, Colin T.; Lu, Xiaowei; Mehta, Anand S.; Angel, Peggi M.; Drake, Richard R.
• Is Part Of: Mass spectrometry reviews. Volume 42:Issue 2(2023)
• Page Start: 674
• Page End: 705
• Publication Date: 2021-08-15
• Subjects: glycosylation -- imaging mass spectrometry -- MALDI -- mass spectrometry -- N‐glycan; Mass spectrometry -- Periodicals; 543
• DOI: 10.1002/mas.21725
• Languages: English
• ISSNs: 0277-7037

Abstract

Abstract: Glycosylation is an important posttranslational modifier of proteins and lipid conjugates critical for the stability and function of these macromolecules. Particularly important are N‐linked glycans attached to asparagine residues in proteins. N‐glycans have well‐defined roles in protein folding, cellular trafficking and signal transduction, and alterations to them are implicated in a variety of diseases. However, the non‐template driven biosynthesis of these N‐glycans leads to significant structural diversity, making it challenging to identify the most biologically and clinically relevant species using conventional analyses. Advances in mass spectrometry instrumentation and data acquisition, as well as in enzymatic and chemical sample preparation strategies, have positioned mass spectrometry approaches as powerful analytical tools for the characterization of glycosylation in health and disease. Imaging mass spectrometry expands upon these strategies by capturing the spatial component of a glycan's distribution in‐situ, lending additional insight into the organization and function of these molecules. Herein we review the ongoing evolution of glycan imaging mass spectrometry beginning with widely adopted tissue imaging approaches and expanding to other matrices and sample types with potential research and clinical implications. Adaptations of these techniques, along with their applications to various states of disease, are discussed. Collectively, glycan imaging mass spectrometry analyses broaden our understanding of the biological and clinical relevance of N‐glycosylation to human disease.